List view / Grid view
3 August 2015 | By Victoria White
Celyad has completed the injection procedure for the last patient enrolled in CHART-1, its Phase III clinical trial of cardiovascular candidate, C-Cure...
3 August 2015 | By Victoria White
Cell Therapy Catapult has awarded a contract to CTL to accelerate its clinical programme to develop an engineered T cell treatment for blood cancers...
3 August 2015 | By Victoria White
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers have found...
3 August 2015 | By Victoria White
A Phase 3 clinical trial met its primary endpoint, showing the benefit of oral telotristat etiprate in treating cancer patients with carcinoid syndrome...
31 July 2015 | By Cobalt Light System
Cobalt is hosting the first ever seminar on the use of Transmission Raman Spectroscopy (TRS) in quantitative pharmaceutical analysis...
31 July 2015 | By Victoria White
People in the UK have little awareness of what ‘antibiotic resistance’ means, according to new research commissioned by the Wellcome Trust...
31 July 2015 | By Victoria White
Merck said today that its Ebola vaccine candidate, rVSV-ZEBOV, was found to have 100% efficacy in an analysis of interim data from a Phase 3 ring trial...
31 July 2015 | By Victoria White
Eisai and Halozyme are to collaborate to evaluate Halaven in combination with PEGPH20 in first line HER2-negative metastatic breast cancer...
31 July 2015 | By Victoria White
Roche submitted the cobas EGFR Mutation Test v2 for Premarket Approval (PMA) to the FDA, as a companion diagnostic test for AZD9291...
31 July 2015 | By Victoria White
Eisai has submitted regulatory applications in the US, EU and Japan for eribulin for the treatment of patients with inoperable soft tissue sarcoma (STS)...
31 July 2015 | By Victoria White
The EC has approved the use of Perjeta in combination with Herceptin and chemotherapy for use before surgery in patients with early stage breast cancer...
30 July 2015 | By Victoria White
Allergan has filed an Abbreviated New Drug Application (ANDA) with the FDA seeking approval to market a generic version of United Therapeutics' Tyvaso...
30 July 2015 | By Victoria White
Astellas has announced that a Phase 3 study evaluating the efficacy and safety of isavuconazole in candidemia did not meet its primary endpoint...
30 July 2015 | By Victoria White
Ascendis Pharma has announced positive top-line results from a study evaluating the safety and efficacy of TransCon Growth Hormone in children with GHD...
30 July 2015 | By Cherwell Laboratories
Cherwell Laboratories, specialists in cleanroom microbiology solutions for the pharmaceutical and related industries, have announced the launch of a refreshed website....
